机器人 mitra 门手术 机器人 mitra 门手术
John Massey1, Kenneth Palmer1, Omar Al-Rawi1
1Department of Cardiothoracic Surgery, The Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Frontiers in cardiovascular medicine
|March 20, 2024
概括
完全内镜的机器人中门修复为中门疾病提供了最少的侵入性方法,比传统的胸腔切除术更快地恢复和更短的住院时间. 这种先进的技术在全球范围内越来越受欢迎,有望改善患者的治疗结果,并在心脏手术中得到更广泛的采用.
科学领域:
- 心血管外科心血管外科
- 最少侵入性的技术
- 机器人手术 机器人手术
背景情况:
- mitra 膜疾病需要手术干预.
- 传统的胸骨切除术带来了显著的患者发病率.
- 寻求最少的侵入性方法来改善外科手术的结果.
研究的目的:
- 审查完全内镜机器人中门修复的优缺点.
- 讨论机器人 mitra 门手术的技术方面.
- 为了预测机器人心脏外科手术的未来趋势.
主要方法:
- 关于机器人中门修复研究的文献综述.
- 分析机器人和胸切除方法之间的比较结果.
- 讨论手术技术和手术设置.
主要成果:
- 机器人 mitra 门手术证明了更快的恢复和更短的住院时间.
- 与胸腔切除相比,机器人中门修复可以降低患病率.
- 在这两种手术方法之间,死亡率和中期耐用性是相当的.
结论:
- 完全内镜式的机器人 mitra 门修复是一种可行的,不那么侵入性的手术选择.
- 预计机器人膜手术的采用将在全球范围内增加.
- 技术和外科医生的技能进步将推动机器人心脏手术的增长.
相关概念视频
Mitral Valve Prolapse I: Introduction
1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
948
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
948
Mitral Regurgitation III: Medical Management
691
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
691
Mitral Stenosis III: Medical Management
539
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539


